Probiotics for chronic low back pain with type 1 Modic changes: a randomized double-blind, placebo-controlled trial with 1-year follow-up using Lactobacillus Rhamnosis GG

ConclusionsNo differences were found regarding the predefined outcomes. Overall, there was little improvement during the 1-year observation period. A small, though hardly clinically relevant, effect on back pain was seen after treatment byLactobacillus Rhamnosis GG, and the treatment was without side effects in comparison with the control group.Graphic abstract
Source: European Spine Journal - Category: Orthopaedics Source Type: research